The survival rate of tuberculosis patients in HIV-treated cohort of 2008-2018 in Almaty, Kazakhstan
Author(s) -
Ainur Zhandybayeva,
Nune Truzyan,
Elina Shahumyan,
Aizat Kulzhabaeva,
Zhamilya Nugmanova,
Alfiya Denebayeva,
Marat Tukeyev
Publication year - 2020
Publication title -
the journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.11955
Subject(s) - medicine , proportional hazards model , hazard ratio , tuberculosis , cohort , confidence interval , survival analysis , population , human immunodeficiency virus (hiv) , retrospective cohort study , cohort study , immunology , environmental health , pathology
HIV/TB comorbidity is responsible for 1.6 million deaths worldwide. HIV/TB control and patients' survival are still among priorities of the national HIV and TB programs. We aimed to evaluate the HIV/TB survival in connection with TB treatment outcomes and factors influencing life duration of the cohort 2008-2018 in Almaty, Kazakhstan.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom